Blueprint Medicines
BioinformaticsCambridge, Massachusetts, United StatesPost-IPO Equity$2.4B total fundingwww.blueprintmedicines.com
Angel investors who backed Blueprint Medicines
25 investors in our database backed Blueprint Medicines.
Rob Faulkner
Board Member
Gerard van Hamel Platerink
Managing Director
Jeffrey Tong
Partner
Abbie Celniker
Partner
Neil Exter
Partner
Craig Muir
Partner and CTO
Cary Pfeffer
Partner
Mark Levin
partner
Walter Kowtoniuk
Venture Partner
Philip Reilly
venture partner
Josephine Kahn
Senior Associate / Consultant
George Xu
Director, Corporate Strategy and Portfolio Development
Noreen Rizvi
Principal
Reid Huber
Partner
Christoph Lengauer
Adjunct Associate Professor
Andrew Warren
Senior Director, CSO Partner Team
Robert Tepper
Partner
William Motley
Senior Associate
Melissa McCracken, PhD
Partner
Thilo Schroeder
Managing Partner
Jakob Loven, PhD
Managing Partner
Rocco Sgobbo
Partner
Marco Weibel
Chief Financial Officer
Thomas Lips
General Partner
Alfred Scheidegger
Founder, Member of the Board of Directors
Find the right investors for your startup
Search thousands of angel investors and VCs by industry, stage, check size, and location — and see who backed companies like Blueprint Medicines.
Search investors